
Primaa is a MedTech company founded in 2018 that offers an AI-based platform for automated and accurate cancer diagnosis. Their technology leverages image analysis and deep learning to enhance detection of major cancer biomarkers, guiding personalized treatment. Key products include Cleo Breast and Cleo Skin, AI assistants designed to detect breast and skin cancer respectively. The platform improves pathologists' workflow by accelerating case reviews, prioritizing cases intelligently, and increasing diagnostic precision, ultimately advancing personalized medicine and patient outcomes. Primaa has achieved CE certification, published scientific articles validating their solutions, and collaborates with leading medical organizations. Their business model is primarily SaaS, targeting pathologists and healthcare providers.

Primaa is a MedTech company founded in 2018 that offers an AI-based platform for automated and accurate cancer diagnosis. Their technology leverages image analysis and deep learning to enhance detection of major cancer biomarkers, guiding personalized treatment. Key products include Cleo Breast and Cleo Skin, AI assistants designed to detect breast and skin cancer respectively. The platform improves pathologists' workflow by accelerating case reviews, prioritizing cases intelligently, and increasing diagnostic precision, ultimately advancing personalized medicine and patient outcomes. Primaa has achieved CE certification, published scientific articles validating their solutions, and collaborates with leading medical organizations. Their business model is primarily SaaS, targeting pathologists and healthcare providers.
Founded: 2018 (Paris, France)
Product focus: AI-powered digital pathology (Cleo Breast, Cleo Skin)
Regulatory milestone: Cleo Breast CE/IVDR certified
Business model: Primarily SaaS targeting pathologists and healthcare providers
Reported funding: $7.58M total (including $5.38M Series A, Nov 2024)
Digital pathology and cancer biomarker detection
2018
Biotechnology Research
$5.38M
Reported November 2024 Series A to support development and international commercialization
Company reports a first equity round in 2019 with 50 Partners
“Has attracted institutional and angel investors across multiple rounds (includes 50 Partners and several other named investors in reporting)”
| Company |
|---|
Primaa:
Primaa is a medtech start-up developing decision support software for cancer diagnosis. The tools that Primaa develops are intended for pathologists, with the aim of assisting them facing the constant increase in the number of cancers, and thus reduce the time of diagnosis to improve the chances of survival for patients.
As a pioneer in its field, Primaa enjoys strong support from the medical ecosystem.
Role:
The product manager is the guarantor of good product development, he steps in during the definition of the need and the use cases but also during the entire life cycle of the product.
Its role revolves around several missions:
The definition of user needs, strategy and positioning of the product, a good knowledge of the market and the competition.
The technical development of the product during the different phases from design to marketing.
Coordination and close collaboration on a daily basis with the various technical teams involved in the development of new innovative products.
Missions:
Profile:
Education:
Recruitment Process:
Benefits: